Cargando…
Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment
Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear protein that regulates gene expression through poly(ADP)-ribosylation, resulting in the loosening of chromatin structure. PARP-1 enzymatic activity has been shown to be necessary for the expression of several genes required for memory formation and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885846/ https://www.ncbi.nlm.nih.gov/pubmed/31827497 http://dx.doi.org/10.1155/2019/4383258 |
_version_ | 1783474803172179968 |
---|---|
author | Regier, Matthew Liang, Jiancong Choi, Alexander Verma, Kavita Libien, Jenny Hernández, A. Iván |
author_facet | Regier, Matthew Liang, Jiancong Choi, Alexander Verma, Kavita Libien, Jenny Hernández, A. Iván |
author_sort | Regier, Matthew |
collection | PubMed |
description | Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear protein that regulates gene expression through poly(ADP)-ribosylation, resulting in the loosening of chromatin structure. PARP-1 enzymatic activity has been shown to be necessary for the expression of several genes required for memory formation and consolidation. Previously, we showed that nucleolar PARP-1 is significantly decreased in hippocampal pyramidal cells in Alzheimer's disease (AD). We proposed that the displacement of PARP-1 from the nucleolus results in downregulation of new rRNA expression and ribosome biogenesis, leading to cognitive impairment. To further investigate the relationship between nucleolar PARP-1 and memory impairment, we examined PARP-1 expression in the hippocampi of individuals with mild cognitive impairment (MCI) compared to control and AD cases. We used immunohistochemical techniques to examine the nucleolar distribution of PARP-1 in the Cornu Ammonis (CA region) of the hippocampus. PARP-1 positive cells were then scored for the presence or absence of PARP-1 in the nucleolus. We found a significant decrease of PARP-1 staining in the nucleolar compartment of hippocampal pyramidal cells in MCI compared with Control and AD. When the four CA (CA1-4) regions were considered separately, only the CA1 region showed significant differences in nucleolar PARP-1 with Control > AD > MCI cases. Categorization of nucleolar PARP-1 into “distinct” and “diffuse” groups suggest that most of the changes occur within the distinct group. In addition, measurements of the nucleolar diameter of nucleolar PARP-1 positive cells in CA2 and CA4 showed Control > MCI. Thus, MCI cases had a lower percentage of PARP-1 nucleolar positive cells in CA1 and smaller nucleolar diameters in CA2 and CA4, compared to Control. Our data suggest that disruption of nucleolar form and function is an early and important step in the progression of cognitive impairment. |
format | Online Article Text |
id | pubmed-6885846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-68858462019-12-11 Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment Regier, Matthew Liang, Jiancong Choi, Alexander Verma, Kavita Libien, Jenny Hernández, A. Iván Neural Plast Research Article Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear protein that regulates gene expression through poly(ADP)-ribosylation, resulting in the loosening of chromatin structure. PARP-1 enzymatic activity has been shown to be necessary for the expression of several genes required for memory formation and consolidation. Previously, we showed that nucleolar PARP-1 is significantly decreased in hippocampal pyramidal cells in Alzheimer's disease (AD). We proposed that the displacement of PARP-1 from the nucleolus results in downregulation of new rRNA expression and ribosome biogenesis, leading to cognitive impairment. To further investigate the relationship between nucleolar PARP-1 and memory impairment, we examined PARP-1 expression in the hippocampi of individuals with mild cognitive impairment (MCI) compared to control and AD cases. We used immunohistochemical techniques to examine the nucleolar distribution of PARP-1 in the Cornu Ammonis (CA region) of the hippocampus. PARP-1 positive cells were then scored for the presence or absence of PARP-1 in the nucleolus. We found a significant decrease of PARP-1 staining in the nucleolar compartment of hippocampal pyramidal cells in MCI compared with Control and AD. When the four CA (CA1-4) regions were considered separately, only the CA1 region showed significant differences in nucleolar PARP-1 with Control > AD > MCI cases. Categorization of nucleolar PARP-1 into “distinct” and “diffuse” groups suggest that most of the changes occur within the distinct group. In addition, measurements of the nucleolar diameter of nucleolar PARP-1 positive cells in CA2 and CA4 showed Control > MCI. Thus, MCI cases had a lower percentage of PARP-1 nucleolar positive cells in CA1 and smaller nucleolar diameters in CA2 and CA4, compared to Control. Our data suggest that disruption of nucleolar form and function is an early and important step in the progression of cognitive impairment. Hindawi 2019-11-19 /pmc/articles/PMC6885846/ /pubmed/31827497 http://dx.doi.org/10.1155/2019/4383258 Text en Copyright © 2019 Matthew Regier et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Regier, Matthew Liang, Jiancong Choi, Alexander Verma, Kavita Libien, Jenny Hernández, A. Iván Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment |
title | Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment |
title_full | Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment |
title_fullStr | Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment |
title_full_unstemmed | Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment |
title_short | Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment |
title_sort | evidence for decreased nucleolar parp-1 as an early marker of cognitive impairment |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885846/ https://www.ncbi.nlm.nih.gov/pubmed/31827497 http://dx.doi.org/10.1155/2019/4383258 |
work_keys_str_mv | AT regiermatthew evidencefordecreasednucleolarparp1asanearlymarkerofcognitiveimpairment AT liangjiancong evidencefordecreasednucleolarparp1asanearlymarkerofcognitiveimpairment AT choialexander evidencefordecreasednucleolarparp1asanearlymarkerofcognitiveimpairment AT vermakavita evidencefordecreasednucleolarparp1asanearlymarkerofcognitiveimpairment AT libienjenny evidencefordecreasednucleolarparp1asanearlymarkerofcognitiveimpairment AT hernandezaivan evidencefordecreasednucleolarparp1asanearlymarkerofcognitiveimpairment |